Transforming vaccinology
R Rappuoli, G Alter, B Pulendran - Cell, 2024 - cell.com
The COVID-19 pandemic placed the field of vaccinology squarely at the center of global
consciousness, emphasizing the vital role of vaccines as transformative public health tools …
consciousness, emphasizing the vital role of vaccines as transformative public health tools …
Vaccine development against tuberculosis before and after Covid-19
SHE Kaufmann - Frontiers in Immunology, 2023 - frontiersin.org
Coronavirus disease (Covid-19) has not only shaped awareness of the impact of infectious
diseases on global health. It has also provided instructive lessons for better prevention …
diseases on global health. It has also provided instructive lessons for better prevention …
COVID-19 booster dose coverage and hesitancy among older adults in an urban slum and resettlement colony in Delhi, India
Background: The high prevalence of vaccine booster hesitancy, with the concomitant
waning of humoral vaccine or hybrid immunity, and the emergence of SARS-CoV-2 variants …
waning of humoral vaccine or hybrid immunity, and the emergence of SARS-CoV-2 variants …
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians
S Rakshit, S Babji, C Parthiban, R Madhavan, V Adiga… - npj Vaccines, 2023 - nature.com
Detailed characterisation of immune responses induced by COVID-19 vaccines rolled out in
India: COVISHIELDTM (CS) and COVAXIN®(CO) in a pre-exposed population is only …
India: COVISHIELDTM (CS) and COVAXIN®(CO) in a pre-exposed population is only …
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults
Due to waning immunity following primary immunization with COVID-19 vaccines, booster
doses may be required. The present study assessed a heterologous booster of SII-NVX …
doses may be required. The present study assessed a heterologous booster of SII-NVX …
Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical …
MA Asante, ME Michelsen, MM Balakumar… - BMC medicine, 2024 - Springer
Background To combat coronavirus disease 2019 (COVID-19), booster vaccination
strategies are important. However, the optimal administration of booster vaccine platforms …
strategies are important. However, the optimal administration of booster vaccine platforms …
[HTML][HTML] Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine …
A Chaudhary, R Madhavan, S Babji, R Raju, C Syed… - Vaccine, 2023 - Elsevier
Infections with SARS-CoV-2 variants and declining immunity after primary vaccination,
encouraged the use of booster doses. Some countries changed their immunization …
encouraged the use of booster doses. Some countries changed their immunization …
An assessment of the strategy and status of COVID-19 vaccination in India
SL Gupta, S Goswami, A Anand, N Naman… - Immunologic …, 2023 - Springer
The COVID-19 disease continues to cause devastation for almost 3 years of its identification.
India is one of the leading countries to set clinical trials, production, and administration of …
India is one of the leading countries to set clinical trials, production, and administration of …
Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized …
Background/Purpose Optimizing vaccine efficacy is of particular concern in patients
undergoing hematopoietic stem cell transplantation (HSCT), which mainly have an …
undergoing hematopoietic stem cell transplantation (HSCT), which mainly have an …
A sustainable vaccine supply-production-distribution network with heterologous and homologous vaccination strategies: Bi-objective optimization
A Jahed, SMH Molana… - Socio-Economic Planning …, 2025 - Elsevier
Abstract Heterologous and homologous Coronavirus Disease 2019 (COVID-19) vaccination
against Severe Acute Respiratory Syndrome (SARS)-CoV-2 are robust and proactively …
against Severe Acute Respiratory Syndrome (SARS)-CoV-2 are robust and proactively …